GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo takes aim at aggressive brain tumor
Disease control CompletedThis study tested a drug called VAL-083, given alongside standard radiation therapy, for people newly diagnosed with an aggressive brain cancer called glioblastoma (GBM). It focused on patients whose tumors have a specific genetic feature (unmethylated MGMT) that makes them less …
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE2 • Sponsor: Kintara Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can a Low-Carb, fasting diet starve brain tumors?
Disease control CompletedThis study tested whether a special diet could help control glioblastoma, an aggressive brain cancer. Researchers had 25 patients who had finished initial treatment try a low-carbohydrate diet combined with short fasting periods. The goal was to see if this diet was practical to …
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with tough brain cancers: first test of a novel drug
Disease control CompletedThis study tested a new oral drug called INCB7839 in children whose aggressive brain tumors had returned or worsened after standard treatments. The main goals were to find the highest safe dose and see how the drug behaves in the body. It involved 13 children and was an early saf…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists test second round of radiation for deadly brain cancer
Disease control CompletedThis study tested the safety of giving a second course of radiation to people whose aggressive brain tumor (glioblastoma) had grown back after initial treatment. The main goal was to find the highest dose of repeat radiation that patients could tolerate without severe side effect…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New scan aims to outsmart Fast-Growing brain tumors
Disease control CompletedThis study tested if a special type of PET scan could help doctors plan better radiation treatment for people with a very aggressive form of brain cancer called glioblastoma. It focused on patients whose cancer showed signs of growing back very quickly after surgery. Researchers …
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE2 • Sponsor: Masaryk Memorial Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New brain cancer drug enters first human safety tests
Disease control CompletedThis was a small, early-stage study to test the safety and dosing of a new drug called tinostamustine for a type of brain cancer called glioblastoma. It involved 10 adults who had recently finished standard radiation and chemotherapy. The main goal was to find the highest dose pa…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Old psychiatric drug repurposed in fight against deadly brain cancer
Disease control CompletedThis small, early-stage study tested whether adding a low dose of an old psychiatric drug called chlorpromazine to the standard treatment for a fast-growing brain cancer (glioblastoma) is safe. Ten adults with newly diagnosed cancer received the drug combination alongside radiati…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New scan aims to sharpen target for brain cancer radiation
Diagnosis CompletedThis study tested whether a newer type of brain scan (FET-PET/MRI) could more accurately map the remaining tumor after surgery compared to the standard MRI scan. The goal was to see if this could help doctors better target radiation therapy, potentially improving treatment effect…
Matched conditions: GLIOBLASTOMA MULTIFORME
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC